Management of Post-Intravitreal Injection Bleeding
In case of post-intravitreal injection bleeding, observation and conservative management is the recommended approach as most cases resolve spontaneously without intervention.
Types of Post-Injection Bleeding
Subconjunctival Hemorrhage
- Most common and benign form of bleeding
- Appears as bright red patch on the white of the eye
- Typically resolves spontaneously within 1-2 weeks
- No specific treatment required beyond reassurance 1
Anterior Chamber Bleeding
- Less common complication
- Can occur without associated vitreous hemorrhage
- Conservative management is appropriate in most cases 2
- Monitor intraocular pressure to ensure no complications develop
Vitreous Hemorrhage
- More serious but less common complication
- May temporarily obscure vision
- Requires careful monitoring but often resolves without intervention
- Position patient with head elevated to help blood settle 1
Management Protocol
Immediate Assessment
- Evaluate visual acuity to establish baseline
- Measure intraocular pressure to rule out pressure-related complications
- Perform slit-lamp examination to determine location and extent of bleeding
- Conduct fundus examination (if possible) to assess retinal status
Management Steps
For minor bleeding (subconjunctival hemorrhage):
- Reassure patient about benign nature
- No intervention required
- Follow-up as scheduled for the underlying condition
For anterior chamber bleeding:
- Conservative management is typically sufficient 2
- Monitor intraocular pressure
- Consider topical anti-inflammatory drops if significant inflammation present
For vitreous hemorrhage:
- Head elevation to allow blood to settle
- More frequent follow-up (1-2 weeks initially) 1
- B-scan ultrasonography if fundus cannot be visualized to rule out retinal detachment
Warning Signs Requiring Urgent Attention
- Sudden worsening of pain or vision
- Significant increase in intraocular pressure
- Signs of infection (increasing redness, pain, photophobia)
- Persistent or worsening hemorrhage
Prevention of Bleeding Complications
- Proper injection technique with needle directed toward optic nerve via pars plana
- Use of povidone-iodine prior to injection
- Adequate anesthesia to prevent sudden movement
- Applying gentle pressure at injection site after needle withdrawal 1
- Consider topical naphazoline to reduce conjunctival hemorrhage 3
Special Considerations
- In patients on anticoagulants, continuation of therapy is generally recommended as the risk of thromboembolic events outweighs the risk of serious hemorrhagic complications 1
- For diabetic patients receiving anti-VEGF injections, regular follow-up is essential as they may be at higher risk for complications 1
Follow-up Schedule
- For minor bleeding: routine follow-up for underlying condition
- For moderate bleeding: 1-week follow-up
- For significant bleeding: 2-3 day follow-up with consideration of more frequent monitoring
Most post-intravitreal injection bleeding is self-limiting and resolves without intervention. The primary focus should be on monitoring for potential complications while providing appropriate reassurance to the patient.